Atricure to participate in the oppenheimer 33rd annual healthcare conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in the upcoming oppenheimer 33rd annual healthcare conference. atricure's management is scheduled to present on wednesday, march 15, 2023 at 8:00 am eastern standard time.
ATRC Ratings Summary
ATRC Quant Ranking